See what questions
a doctor would ask.
A study published in the Journal of the American Geriatrics Society shows that risedronate (Actonel) can reduce the risk of vertebrae fractures due to osteoporosis in women over 80 by slowing the rate of bone resorption. In the study, 2.5% of the female subjects taking risedronate suffered new vertebral fractures after 1 year compared to 10.9% of the placebo subjects. After 3 years 18.2% of the risedronate suffered new fractures compared to 24.6% of the placebo group. Thus, the study shows that osteoporosis treatment is worthwhile even in the very elderly.
Source: summary of medical news story as reported by Reuters - Journal of the American Geriatrics Society, 2004
About: Osteoporosis drug effective even in the very elderly
Date: 3 December 2004
Source: Reuters - Journal of the American Geriatrics Society, 2004
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City